Navigation Links
BioNeutral Group Expands The Testing Of Its Ygiene Sterilant Against Anthrax Spores
Date:7/3/2012

MORRISTOWN, N.J., July 3, 2012 /PRNewswire/ -- BioNeutral Group, Inc. (OTCBB: BONU) a specialty life science technology based company announced today that it has contracted Battelle to test its Ygiene Sterilants against Bacillus anthracis Ames Spores. These tests are designed to determine the efficacy of Ygiene under conditions which simulate actual contaminated environments and to determine applicability for military and homeland security utilization. Testing is expected to commence shortly.

BioNeutral's Dr. Andy Kielbania said, "We are extremely pleased to have the opportunity to work with  a well-known organization like Battelle. We believe this non-clinical laboratory testing of our Ygiene Sterilants is a critical step in moving our product line into highly specialized applications. The results from this study along with our association with DLA Piper and Senator Daschle will allow us to properly position our products for government applications."

About Battelle

Battelle is the world's largest private, independent research and development organization. For more information see www.battelle.org

About BioNeutral Group, Inc.

Headquartered in Morristown, New Jersey with lab facilities at the New Jersey Institute of Technology in Newark, Inc., is a specialty technology-based life-science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene® and Ogiene®, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene® brand have been approved by the EPA for sale in the United States
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioNeutral Group Appoints A New Member to the Board of Directors
2. BioNeutral Group Receives $400,000 in Equity Financing
3. Foundation Venture Capital Group Makes Eighth Start-Up Investment
4. Hark! Group demonstrates first heralded single photon source made from silicon
5. Butamax Early Adopters Group surpasses capacity targets with addition of Big River; Membership represents 11 production facilities and nearly 900 million gallons of ethanol capacity
6. aTyr Pharma Receives Industry Innovation Awards from TiE and San Diego Venture Group
7. Nitor Group Demonstrates Direct Product Suite at Direct Implementation and Adoption Summit May 31-June 1
8. Mindray Renews Agreement with HealthTrust Purchasing Group, L.P. to Provide Patient Monitoring Equipment
9. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
10. MiMedx Group Announces Record First Quarter Results
11. SOCMA Announces Launch of SCD-iBIO Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... new study led by George Washington University Professor ... of ice in small droplets is strongly size-dependent, ... the nanoscale. The formation of ice at the ... whose answer also has important implications for climate ... of ice from supercooled water is generally initiated ...
(Date:5/21/2013)... , May 21, 2013 ... Dialysis and Transplant Association) is the biggest congress in ... replacement therapy. Nearly 10,000 participants are in ... the latest research findings. New pioneering studies have been ... "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA ...
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5
... China, May 14 Simcere Pharmaceutical,Group (NYSE: SCR ), ... of the patented anti-cancer biotech,product Endu in China, today announced ... conferences:, * Brean Murray Carret & Co. ... Waldorf-Astoria in New York on Monday, May 19, 2008 at ...
... 14 SynCo Bio Partners B.V., a leading,GMP ... manufacture and release of ActoGeniX, drug substance AG011 ... ulcerative colitis patients., ActoGeniX is focused on ... of protein-based biopharmaceuticals that can,be orally administered. The ...
... CITY, New Jersey, May 14, Rosetta Genomics (Nasdaq: ... results on May 21, 2008, before the,U.S. markets open. ... webcast to discuss these results at 4:30 p.m. ET ... call, U.S. and Canadian participants may,dial +1-866-966-5335; international participants ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 3Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results 2
(Date:5/21/2013)... of all types become most deadly when they metastasize ... reached this stage, it becomes very difficult for doctors ... develop. Now, researchers at the University of Missouri have ... lymphoma tumor cells wherever they may be in the ... the MU College of Veterinary Medicine, says being able ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... genes function without changing the underlying DNA sequence, ... pregnant women during any trimester, potentially providing a ... after giving birth, and an opportunity to intervene ... the small study involving 52 pregnant women are ... . , "Postpartum depression can be harmful to ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... small biotech company in Boulder, CO, announced today that they ... The FluChip was invented by a joint team of ... Disease Control and Prevention in an NIH sponsored effort led ... CEO of InDevR, said that InDevR has arranged to test ...
... grants totaling $24 million in U.S. dollars have ... hospitals to fund studies related to asthma and ... cancer. The extramural grants were awarded by ... for Science, Technology and Research), the government agency ...
... The Entomological Society of America (ESA) will feature ... Meeting in Indianapolis, December 13-16, 2009. Integrative ... Cold Case Files: Integrative Perspectives on Physiological ... Evolutionary Arms Race of Resistance in Herbivores ...
Cached Biology News:FluChip technology licensed to combat deadly flu virus 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Symposia selected for Entomological Society of America meeting 2Symposia selected for Entomological Society of America meeting 3Symposia selected for Entomological Society of America meeting 4
... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... Last innovation from Magnetofection technology, SilenceMag ... system available. Simple, rapid and easy ... and non toxic. Specifically designed for ... silencing at very low doses of ...
... 4 H 10 O 2 S ... SPECIFICATIONS Form: White crystalline powder Assay: ... Identity: By IR Melting Point: greater ... DTT: less than or equal to ...
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
Biology Products: